NEU 3.04% $20.09 neuren pharmaceuticals limited

Trof Pricing - name your price, page-20

  1. 375 Posts.
    lightbulb Created with Sketch. 1096
    If the average orphan drug price is now $200k , and Trof 1) is the only approved treatment for Retts, 2) produces a robust improvement and 3) treats a disease with a very high burden (which is true for Retts) then logically the price for Trof should be at the upper end of the range. Acadia's first obligation is to maximise its return for shareholders, which means they should be pricing at the maximum the market can bear (i.e. maximising penetration times price).

    Based on the information we have its hard to see how the price will end up lower than $200k, let alone the $50k to $100k some are suggesting.

    This information suggests to me a price well over $200k. i.e. $250k seems far more likely to me than $150k.
    Last edited by Kjt1969: 09/01/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.09
Change
-0.630(3.04%)
Mkt cap ! $2.570B
Open High Low Value Volume
$20.41 $20.45 $20.02 $1.127M 55.93K

Buyers (Bids)

No. Vol. Price($)
1 125 $20.09
 

Sellers (Offers)

Price($) Vol. No.
$20.10 92 5
View Market Depth
Last trade - 11.12am 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.